Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Downgrades Cree (CREE) to Hold; GM Expansion Played Out
-
StreetInsider.com Pre-Open Movers 01/04: (FOLD) (HNR) (KKD) Higher; (ARAY) (FINL) (LULU) Lower (more...)
-
StreetInsider.com After-Hours Movers 01/03: (SHLM) (ROVI) (CYTK) Higher; (ARAY) (ITMN) (CSTR) Lower (more...)
-
Insulet (PODD) Sells $85M Common Stock
-
2013 Could be a Blockbuster Year for Amarin (AMRN) and It All Starts Next Week - Analyst
-
Canaccord Genuity Raises Price Target On Insulet (PODD)
-
Streetinsider.com's Hot Lunchtime Reads 12/20: (AMRN) (DKS) (ZNGA) (BAC) (AAPL)
-
Canaccord Genuity Cuts PT on Amarin (AMRN) But Still Sees a Double
-
Canaccord Genuity Bumps Price Target on Headwaters (HW) to $10
-
Headwaters (HW) Prices Upsized 10M Offering at $7.25/Share
-
Canaccord Genuity Downgrades PDC Energy (PDCE) to Hold
-
Canaccord Genuity Starts Biogen (BIIB) at Hold
-
Canaccord Genuity Assumes Triangle Petroleum (TPLM) at Buy
-
Notable Analyst Rating Changes 12/17: (INFA) (ALU) (DAL) Upgraded; (AAPL) (SD) (TXN) Downgraded
-
Canaccord Genuity Cuts Est., PT on Apple (AAPL) on Softer iPad Sales and Mix, Lower iPhone Sales
-
Canaccord Genuity Downgrades USANA Health Sciences Inc. (USNA) to Hold
-
Canaccord Genuity Downgrades Finish Line (FINL) to Hold
-
Canaccord Genuity Downgrades SandRidge Energy (SD) to Sell
-
Rochdale's Bove ISN'T Going to Canaccord, But He'll End Up in NYC - FBN
-
Investors Cautions on Globus Medical (GMED) as Lockup Expiration Looms
-
Sarepta Therapeutics (SRPT) 4.95M Share Offering Priced at $25.25
-
Conn’s (CONN) Closes 5.5M Offering; Reaffirms Outlook
-
Canaccord Genuity Starts Approach Resources (AREX) at Buy
-
Investor Meeting is Potential Catalyst for Teva (TEVA)
-
Williams-Sonoma (WSM) Underappreciated, Says Analyst
-
Q2 Results Remove Uncertainty in Hi Tech Pharmacal (HITK)
-
Canaccord Trims PT on Amarin (AMRN); Sees Increased Commercial Risk, Still Positive on NCE
-
Conn's (CONN) Prices Larger 5.5M Offering at $26.75/Share
-
Canaccord Genuity Downgrades DragonWave (DRWI) to Hold
-
AcelRx Pharma (ACRX) Prices Upsized 12.5M Offering at $3.31/Share
-
Derma Sciences (DSCI) Prices 3.06M Offering at $10.34/Share
-
Nuance's (NUAN) Day Has Arrived, Says Analyst
-
Nokia Siemens Agrees to Sell Business Support Unit to Redknee (NOK) (SI)
-
AcelRx Pharma (ACRX) Announces 10M Common Offering
-
Broadcom (BRCM) May Lift Guidance as Analyst Day Approaches
-
Canaccord Genuity Reiterates Buy on United Natural Foods (UNFI)
-
Apple (AAPL) iPhone 5 Shipment Times Now Down to Days
-
Analyst Keeps Quidel (QDEL) At Buy as CDC Sees Uptick in Influenza
-
Teva Pharma (TEVA) Investors Look To Analyst Day
-
Notable Analyst Rating Changes 12/03: (DELL) (ITUB) (IGT) Upgraded; (RIMM) (QLGC) (BSBR) Downgraded
-
StreetInsider.com Pre-Open Movers 12/3: (SVU) (DECK) (DELL) Higher; (MYGN) (HMA) (RIMM) Lower (more...)
-
Nokia's (NOK) Lumia Sales Show Promise, But That's It - Canaccord Genuity
-
UPDATE: Canaccord Genuity Starts Lululemon Athletica Inc. (LULU) at Buy
-
Canaccord Genuity Bumps Estimates on Apple (AAPL) Higher After Checks Show "Very Strong" Sales
-
UPDATE: Canaccord Genuity Downgrades Research In Motion Ltd. (RIMM) to Sell, Fundamentals Still Stink
-
Canaccord Genuity Downgrades Bankrate (RATE) to Hold
-
Canaccord Genuity Reiterates Buy on Avanir (AVNR) as Drug Sales Ramp
-
Canaccord Genuity Upgrades Randgold Resources Ltd. (GOLD) to Buy
-
Canaccord Genuity Boosts Target on Mylan (MYL), Answers 5 Key Questions
-
Canaccord Genuity Lifts PT on Green Mountain (GMCR) to $45

